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We have measured the efficiencies of two novel pseudo-peptidic carriers and various cell-penetrating peptides (Penetratin, (Arg)9 and the third
helix of the homeodomain of Knotted-1) to deliver the same cargo inside cells. The cargo that was studied corresponds to the pseudo-substrate of
protein kinase C. Cargo delivery was quantified using a recent method based on isotope labeling and MALDI-TOF MS. Results of cargo delivery
were compared to the amounts of free CPP internalized inside cells. The third helix of Knotted gave the best results concerning free CPP cellular
uptake. It was also found to be the most efficient carrier. This peptide thus emerges as a new CPP with very promising properties.
© 2006 Elsevier B.V. All rights reserved.Keywords: Cell-penetrating peptide; Cargo delivery; Quantification; MALDI-TOF MS1. Introduction
The study of protein internalization and the identification of
the domain responsible for their cellular uptake led to theAbbreviations: Acm, acetamidomethyl; Boc, tert-butoxycarbonyl; BSA,
bovine serumalbumin; CHCA, α-cyano-4-hydroxycinnamic acid; CHO,
Chinese hamster ovary; CPP, cell-penetrating peptide; H-CPP, non-deuterated
cell-penetrating peptide; D-CPP, deuterated cell-penetrating peptide; 2Cl-Cbz,
2-chlorobenzyloxycarbonyl; DCC, dicyclohexylcarbodiimide; DMEM, Dubelc-
co's modified eagle medium; DIEA, diisopropylethylamine; DMF, N, N-
dimethylformamide; DTT, dithiotreitol; EDTA, ethylenediamine tetraacetic
acid; HATU, N-[(dimethylamino)-1H-1,2,3-triazolo[4,5-b]pyridin-1-ylmethy-
lene]-N-methylmethanaminium hexafluorophosphate N-oxide; HBTU, N-
[(1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-methylmethanaminium
hexafluorophosphate N-oxide; HOAt, 1-hydroxy-7-aza-benzotriazole; HOBt, 1-
hydroxybenzotriazole; HPLC, high performance liquid chromatography;
MALDI-TOF MS, matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry; MBHA-PS, 4-methylbenzhydrylamine polystyrene; 4-
MeOBzl, p-methoxybenzyl; Npys, 3-nitro-2-pyridinesulphenyl; PyAOP, 7-
Azabenzotriazol-1-yloxytris(pyrrolidino)phosphonium hexafluorophosphate;
PKC, protein kinase C; PKCi, proteins kinase C inhibitor; PyBOP,
benzotriazol-1-yloxytris(pyrrolidino)phosphonium hexa-fluorophosphate;
SEM, standard error of the mean; TFA, trifluoroacetamide; TFFH, tetramethyl-
fluoroformamidinium hexafluorophosphate; THF, tetrahydrofuran
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doi:10.1016/j.bbamem.2006.01.012discovery of the first short Cell-Penetrating Peptides (CPPs)
corresponding to Penetratin derived from the Antennapedia
homeodomain [1] and to Tat-derived peptides [2]. Many other
CPPs have been described soon after corresponding to protein
transduction domains or consisting of chimeric and synthetic
peptides : nuclear localization sequences (NLS) [3,4], Trans-
portan [5], Model Amphipatic Peptides (MAP) [6], polybasic
peptides [7,8], amphipathic proline-rich peptides [9], and β-
peptides [10]. It has been demonstrated that some CPPs retain
the capacity to translocate the plasma membrane even when
coupled to hydrophobic or acidic cargoes (e.g., peptides,
oligonucleotides, drugs, etc.) [11]. These were named Trojan
peptides for their ability to deliver into cells molecules that alone
are not internalized efficiently [12]. Different methods have been
reported to quantify the CPPs cellular uptake [13]. Most of them
are based on the use of peptides labeled by a reporter group such
as biotin [1] or a radioisotope [5,14,15]. Fluorescent peptides are
also very frequently used and have been quantified by flow
cytometry [16], fluorescence correlation microscopy [17], or
resonance energy transfer [18]. The results reported for the CPPs
cellular uptake efficiencies strongly differ from one study to
another. For example, the ratio between the intracellular and
extracellular concentrations for Penetratin ranges from 0.6 [17]
to 95.0 [19]. The discrepancies observed between studies may be
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internalization to distinguish between the internalized and
membrane-associated peptides. It has recently been shown that
cell washing with buffer is not sufficient to completely remove
the membrane-bound peptide [16]. Discrimination between
internalized and membrane-associated peptide is often achieved
by enzymatic digestion of the non-internalized peptide [20] that
may be combined with an heparin treatment [21], by chemical
modification [22], or by fluorescence quenching [18,23]. The
quantification methods generally give the total amount of
internalized CPP or cargo with no possible distinction between
the intact and degraded forms. In two cases, fluorescenceFig. 1. (A) Construction used for free CPP quantification by MALDI-TOF MS.
Internalized CPPs (H-CPPs) are functionalized by an isotope tag composed of
four non-deuterated glycine residues, internal standards (D-CPP) are functio-
nalized by four bi-deuterated glycine residues. (B) Construction used for cargo
delivery quantification. The internalized species correspond to the conjugates
functionalized by four non-deuterated glycine residues. The internal standard
corresponds to the free cargo functionalized by four bi-deuterated glycine
residues. The sequences of the CPPs, pseudo-peptidic carriers and cargo are
indicated.quantification has been combined with a technique of peptide
separation such as HPLC [22] or Cell Activity by Capillary
Electrophoresis [24] so that modifications of the CPP or of the
cargo could be detected. We have recently reported a method to
measure CPP cellular uptake bymatrix-assisted laser desorption/
ionization time-of-flight mass spectrometry (MALDI-TOF MS)
[25]. It is based on the combined use of affinity purification of
biotinylated CPPs from cell-lysate by streptavidin-coated
magnetic beads [26,27] and isotope labeling [28]. This method
gives the amount of intact internalized CPP and allows the direct
characterization of peptide modifications. It has now been
adapted to measure the amount of cargo delivered inside cells by
the CPP to study the ability of CPPs to act as Trojan peptides.
The cargo that was chosen corresponds to a hydrophilic peptide
inhibitor of Protein Kinase C (PKC) [29]. PKC isozymes
represent an important pharmacological target since they play
key roles in the regulation of cell growth and in pathological
developments including cell transformation [30], cancer pro-
gression [31] and drug-resistant neoplastic phenotype [32,33]. It
has previously been shown that the PKC peptide inhibitor used
in this study (PKCi, Fig. 1) does not inhibit protein
phosphorylation in cell culture [34,35]. Indeed, despite its
cationic character, this peptide is not able to reach the cytoplasm
where the PKC isozymes are located. Several strategies have
been used for its cellular delivery leading to a fast inhibition of
phosphorylation: (1) lipid addition to the cell culture to
permeabilize membranes, (2) intracellular injection [36], (3)
peptide chemical modifications including N-myristoylation
[34,37], N-palmitoylation [38], S-farnesylation [39], and
conjugation to a CPP [35]. The present work focuses on the
quantification of the delivery of this peptide inhibitor by
different Trojan carriers including Penetratin, (Arg)9, the new
CPP corresponding to the third helix of Knotted-1 home-
odomain (Kno) and two novel pseudo-peptidic carriers (Fig. 1).
Results are compared to the amounts of free CPPs internalized
inside cells that have been measured previously [25,40].
2. Materials and methods
2.1. Reagents
Standard Boc amino acids, MBHA-PS resin and HBTU were purchased
from Senn Chemicals. Solvents (peptide synthesis grade), DCC, HOBt, and
PyAOP were obtained from Applied Biosystems. HOAt was purchased from
Fluka. [2,2-D2, 98%]-N-Boc-glycine was obtained from Euriso-top.
2.2. Synthesis of the CPPs
Peptides were assembled by stepwise solid-phase synthesis on a ABI 433A
peptide synthesizer (Applied Biosystems) using standard Boc strategy (MBHA-
PS resin with a loading of 0.9 mmol NH2/g, amino acid activation with DCC/
HOBt or HBTU) on a 0.1 mmol scale. The peptides were cleaved from the resin
by treatment with anhydrous HF (1h30, 0 °C) in the presence of anisole (1.5 mL/
g peptidyl-resin) and dimethylsulfide (0.25 mL/g peptidyl-resin) following the
standard procedure. They were purified by preparative reverse-phase HPLC on a
C8 column, using a linear acetonitrile gradient in an aqueous solution containing
0.1% (v/v) trifluoroacetic acid. Peptides were obtained with a purityN95%, as
assessed by analytical HPLC. They were characterized by MALDI-TOF MS
(Voyager Elite, PerSeptive Biosystems) in positive ion reflector mode using the
matrix CHCA. Delayed extraction was optimized for 20 kVacceleration voltage
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molecule (first isotope) are given as experimental (theoretical): H-Penetratin,
2699.3 (2699.5); D-Penetratin, 2707.3 (2707.5); H-Kno, 2649.3 (2649.4); D-
Kno, 2657.4 (2657.4); H-(Arg)9 1877.2 (1877.1); D-(Arg)9 1885.2 (1885.1); D-
PKCi-SH, 2108.0 (2108.1); PKCi-SAcm 2156.5 (2156.1).
2.3. Synthesis of the pseudo-peptidic carriers P1 and P2
Amounts of reagent are given in equivalents with respect to the peptidyl-
resin unless mentioned otherwise. P1 and P2 were synthesized manually using
solid-phase Boc strategy on MBHA-PS resin (72 mg, 0.05 mmol). Boc-Cys(4-
MeOBzl)-OH and Boc-βAla-OH (10 equiv.) were activated by treatment for 5
min with HBTU (9 equiv.) and DIEA (20 equiv.) in DMF (final concentration of
activated amino acid: 0.45M). Each coupling was allowed to proceed for 30 min
under a stream of argon at room temperature. Units U1, U2 and U3 (5 equiv.)
were mixed with PyAOP (6 equiv.), HOAt (6 equiv.) and DIEA (20 equiv.) in
DMF (final concentration of amino acid 0.29 M) before addition to the peptidyl-
resin. Each coupling was allowed to proceed for 12 h at 50 °C under a stream of
argon. Double coupling were used. Completion of the reaction was monitored
by the Kaiser test. Capping of the unreacted amino groups was performed by
treatment of the peptidyl-resin with acetic anhydride (10% in DMF) for 30 min.
The Boc protecting group was removed by treatment with trifluoroacetic acid for
3 min. The pseudo-peptide P1 was synthesized by the consecutive assembly of 3
units U1 and 1 U2. The side-chains of U2 were deprotected with trifluoroacetic
acid. 1H-indol-3-acetic acid (20 equiv.) was preactivated for 5 min with HBTU
(18 equiv.) and DIEA (40 equiv.) in DMF (final concentration of preactivated
acid 0.45 M) and coupled to P1 overnight under a stream of argon at room
temperature. The resin-bound polymer P1 was washed with THF, suspended in
18 mL of a mixture of NaOH (2 M) / THF (1:2, v/v) and stirred for 24 h to
remove the TFA protecting groups. The resin was washed several times with a
mixture of water and THF and with pure THF. The pseudo-peptide P2 was
assembled from 3 units U3 and 1 U2. The protecting groups of the side-chains of
U2 were removed with trifluoroacetic acid before HF clivage. Cleavage of the
polymers P1 and P2 from the solid support was carried out by treatment with HF
(2 h, 0 °C) in presence of anisole (1.5 mL/g peptidyl-resin), dimethylsulfide
(0.25 mL/g peptidyl-resin) and p-thiocresol (300 mg/g peptidyl-resin). After HF
removal under vacuum, the peptide was precipitated in cold diethyl ether and
dissolved in a degassed aqueous solution of acetic acid (10%). Polymers P1 and
P2 were freeze-dried.
2.4. Synthesis of the carrier-cargo conjugates via disulfide bridge
The crude polymers P1 and P2 were dissolved in a degassed solution of 10%
acetic acid and mixed with a slight excess of peptide PKCi-Cys(Npys) (about
1.5 equiv.). The reaction was followed by HPLC and conjugates were purified
by reverse-phase HPLC on a C8 column, using a linear gradient of acetonitrile in
an aqueous solution containing 0.1% (v/v) trifluoroacetic acid. The same
procedure was used to synthesize the CPP-cargo conjugates from the purified
CPP-Cys and PKCi-Cys(Npys) peptides. Conjugates were characterized by
MALDI-TOF MS in positive ion reflector or linear mode using the CHCA
matrix. For the protonated conjugates at m/zb3600, the first isotope was
detected: C4 (PKCi-S-S-P1) 3543.0 (3541.9); C5 (PKCi-S-S-P2) 3228.1
(3227.8). For the protonated conjugates at m/zN3600, the average m/z was
determined: C1 (PKCi-S-S-Penetratin), 4490.0 (4489.4); C2 (PKCi-S-S-(Arg)9)
3667.1 (3666.4); C3 (PKCi-S-S-Kno) 4442.1 (4439.3). Them/z values are given
as experimental (theoretical).
2.5. Measure of the cellular uptake by MALDI-TOF MS
The internalization experiments were performed using 12-well plates. In each
well, 106 adherent CHO K1 cells were incubated for 75 min at 37 °C with 1 mL
culture medium (DMEM) containing the biotinylated non-deuterated CPP (H-
CPP) or the conjugate (H-PKCi-S-S-Carrier) (7.5 μM). The cells were then
washed 3 timeswith 2mL culturemedium, treated for 3min at 37 °Cwith 500 μL
of a solution containing 0.05% trypsin, 0.02% EDTA and transferred at 4 °C.
Soybean trypsin inhibitor (100 μL, 5 mg/mL) and BSA (100 μL, 1 mg/mL) were
added. The cell suspension was transferred in a 1.5-mL conic tube and the wellwas washed with 500 μL of 50 mM Tris–HCl buffer (pH 7.4). Both suspensions
were pooled and centrifuged for 2 min at 3000 rpm. The pellet containing the
intact cells was washed with 1 mL of 50 mM Tris–HCl buffer (pH 7.4), 0.1%
BSA (buffer A) and centrifuged again. The pellet was mixed with a known
amount of the adequate biotinylated deuterated standard (D-CPP or D-PKCi-SH)
and 150 μL of a solution containing 0.3% Triton X100 and 1 M NaCl. The
mixture was heated for 15 min at 100 °C. The cell lysate was then centrifuged for
5 min at 10,000 rpm at 4 °C. The supernatant was mixed with 850 μL of buffer A
in the case of CPP quantification or buffer A containing 2 mMDTT in the case of
cargo (PKCi) quantification. The mixture was incubated for 2 h at 4 °C with 100
μg streptavidin-coated magnetic beads (Dynabeads M-280, Dynal, France) to
capture the biotinylated peptides. After bead immobilization with the Dynal
magnetic particule concentrator, the supernatant was removed. Beads were
washed twice with buffer A (200 μL), twice with buffer A containing 0.1%
sodium dodecylsulfate (200 μL), twice with buffer A containing 1 M NaCl (200
μL) and with water (2×200, 100, 3×50 and 10 μL). Beads were mixed with 3 μL
of a saturated solution of CHCA in acetonitrile/water–0.1% trifluoroacetic acid
(4:1) and 1 μL of the mixture was deposited on the MALDI-TOF sample holder.
The samples were analyzed byMALDI-TOFMS (ion positive reflector mode) on
aVoyager Elite PerSeptive Biosystemsmass spectrometer. The laser fluence used
was near the threshold of peptide ions production for the considered deposits
(bead-associated peptide covered with CHCA matrix). Spectra were averaged
from several hundred laser shots recorded on different spots of the deposit to get
an isotope pattern similar to that expected. The area of the [M+H]+ signals
including all the isotopes of the intact non-deuterated species (H-CPP or H-
PKCi-SH) and deuterated species (D-CPP or D-PKCi-SH) were measured. The
amount of internalized species was calculated from the areas' ratio. In the first
experiment, the amount of internalized peptide was evaluated for each CPP or
conjugate by adding various and known amounts of the adequate standard to
samples containing the internalized peptide. The amount of standard added in the
subsequent experiments was chosen to get a peptide ratio close to 1:1 to allow a
precise quantification. The internalization experiments were performed in
duplicates and repeated at least four times independently. To quantify the
internalization of the free cargo H-PKCi-SAcm, a known amount D-PKCi-SH
was added to the sample before cell lysis, the lysate was then mixed with 850 μL
of buffer A containing 2 mM DTT and 20 mM iodoacetamide and incubated for
2 h at 4 °C with the streptavidin-coated magnetic beads.
3. Results
3.1. Synthesis of the pseudo-peptidic cationic carriers
P1 and P2
Two new pseudo-peptidic carriers P1 and P2 incorporating in
their sequence the α,α-disubstituted amino acid bis-ornithine
(2,2-bis (aminopropyl)glycine) have been synthesized (Fig. 1).
Consecutive bis-ornithine residues are separated in the poly-
mers by a β-alanine. P1 is functionnalized by six amine and two
indol groups whereas P2 contains eight amine groups. Indols
were introduced in P1 in an attempt to increase the affinity of
the carrier for the cellular membrane.
The different units U1 to U3 (Fig. 2) containing the residue
bis-ornithine were prepared in solution. (Aussedat, B, unpub-
lished data). These units were protected differently on the side-
chains of the bis-ornithine in order to allow the future
preparation of a small library of polymers with various amine
functionalizations. Polymers P1 and P2 were synthesized on
solid support from units U1 to U3 after optimization of the
coupling conditions. We first tested the activation of the
dipeptidic units by HBTU, HATU, PyBOP or TFFH. In each
case, the activated ester was reacted for 12 h at 50 °C with the
elongating polymer and double or triple couplings were
performed. The best result was obtained with HATU but the
Fig. 2. (A) Units containing bis-ornithine. (B) Synthesis of the pseudo-peptidic carrier P1. (a) trifluoroacetic acid 3 min then double coupling of U1 activated in situ by
PyAOP/HOAt/DIEA in DMF, 50 °C for 12 h (3 cycles). (b) trifluoroacetic acid 3 min then double coupling of U2 activated in situ by PyAOP/HOAt/DIEA in DMF,
50 °C for 12 h. (c) trifluoroacetic acid 3 min then coupling of 1H-indol-3-acetic acid activated by HBTU/DIEA in DMF, 12 h room temperature. (d) NaOH/water/THF
then HF cleavage.
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activated in situ with a mixture of PyAOP and HOAt were
reacted for 12 h at 50 °C with the polymer and double couplings
were used, couplings were found to be almost complete (no
aborted polymer detected after cleavage from the support). P1
was synthesized by consecutive coupling of three units U1
protected on the side-chains by a trifluoroacetamide group and
one unit U2 protected by Boc (Fig. 2). Indol groups were
introduced on the side chain of the N-terminal unit after Boc
removal (Fig. 2). Two major compounds were detected in the
crude mixture after cleavage of the polymer from the resin.
These were separated by HPLC and characterized by MALDI-
TOF MS. The major compound was found to be the expected
product P1 whereas the side-product was identified as the
polymer containing a dehydro-alanine instead of a cysteine at the
C-terminus. The formation of dehydro-alanine probably took
place during the removal of the trifluoroacetamide groups using
stringent basic conditions. Although, the formation of this side-
product may be avoided by optimizing the deprotection
conditions (use of shorter reaction times), we chose to change
protecting group in the subsequent polymer synthesis. P2 was
assembled from units U3 and U2. After cleavage from solid
support by treatment with HF, the crude polymers containing a
free cysteine were conjugated in solution to the PKCi cargo
containing a cysteine activated by a 3-nitro-2-pyridinesulfenyl
(Npys) group. Conjugates were purified by reverse phase HPLC.3.2. Quantification of the cellular uptake by MALDI-TOF MS
The measure of cellular uptake of free CPPs has been
performed using the method based onMALDI-TOFMS recently
described by our group [25]. Peptide quantification by MALDI-
TOFMS is achieved by using an internal standard corresponding
to a peptide with the same sequence but labeled with a stable
isotope. The CPPs have the general structure represented in Fig.
1A. They are functionalized on their N-terminus by biotin plus
an isotope tag composed of four non-deuterated glycine residues
for the internalized species (H-CPP) and four bi-deuterated
glycine residues for the standard (D-CPP). A known amount of
standard is added at the end of the incubation of the H-CPP with
cells before lysis. The biotinylated peptides are extracted from
the lysate, concentrated and desalted using streptavidin-coated
magnetic beads to allow the analysis by MALDI-TOF MS.
Because both H-CPP and D-CPP have the same sequence, they
have the same affinity for the streptavidin-coated beads and
exhibit the same efficiency of desorption/ionisation by MALDI-
TOF MS. Therefore, the relative intensity of their signals on the
mass spectra corresponds to their relative proportion in the
sample. The amount of intact internalized peptide is calculated
from the ratio between the peak areas of H-CPP and D-CPP
([M+H]+ peak of the intact peptides, Fig. 3A). Because of the
non-complete deuteration of the D-CPPs (typically 98% of the
peptides contain 8 deuteriums and 2% contain 7 deuteriums) and
Fig. 3. (A) MALDI-TOFmass spectrum obtained for the cellular uptake of Kno. The peaks atm/zb1000 correspond to the matrix or polymer covering the streptavidin-
coated magnetic beads. The insert shows the [M+H]+ peaks of the intact non-deuterated (H-Kno) and deuterated peptide (D-Kno). (B) Total amount of intact
internalized free CPP in 106 CHO cells. (C) Total amount of intact internalized PKCi in 106 CHO cells for the different conjugates (carriers are indicated under
brackets). Each data is the average result of at least three independent experiments performed in duplicates or triplicates±S.E.M.
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quantification is based upon the sum of the peaks area of all
isotopes for both H-CPP and D-CPP (including the D7 and D8
components) after background subtraction. Similar results are
observed using peaks height instead of peaks area. We have also
observed that using the sum of the peaks area of all isotopes
gives a lower scattering in the quantification compared to using
the peak height of the first or the most abundant isotope.
Using this method, we had previously measured the
amount of internalized free CPP in CHO cells after 75 min
incubation at 37 °C at a concentration of 7.5 μM (Fig. 3B).
Kno gave the highest amount of intact intracellular peptide
with 37.8±2.3 pmol (mean value±S.E.M., n=8) in 106 cells
[40]. This corresponds to an estimated intracellular concen-
tration of 25.2±1.5 μM based on a volume per cell of 1.5
pL. (Arg)9 and Penetratin gave intracellular concentrations of
4.5±0.4 μM (n=8) and 3.4±0.2 μM (n=12), respectively
[25]. No intense signals corresponding to an intracellular
degradation have been detected for these CPPs.
The method has been adapted here to measure the amount of
cargo delivered inside cells by a carrier. For this purpose we
designed the construction presented in Fig. 1B in which the
cargo is functionalized by the biotin and the isotope tag and is
linked via a disulfide bridge to the carrier. The cargo is expected
to be released from the carrier after disulfide bond reductioninside cells [41,42]. The species quantified byMALDI-TOFMS
in this experiment thus corresponds to the free cargo and the free
deuterated cargo must be used as internal standard. The cargo
studied here is the peptide PKCi which is an inhibitor of protein
kinase C (Fig. 1B). The first internalization experiment was
performed with the conjugate PKCi-S-S-Penetratin (C1) using
the protocol that was developed previously to quantify the free
CPP cellular uptake. We then observed on the mass spectra the
signals of non-deuterated and deuterated PKCi-SH as well as
less intense signals corresponding to PKCi-S-S-glutathione
conjugates. No signal corresponding to the conjugate C1 was
detected. It was found that both deuterated and non-deuterated
PKCi-SH peptides had reacted with glutathione to the same
extent showing that adduct formation occurred after cell lysis
most certainly during the step of peptide capture by streptavidin-
coated beads. To avoid the formation of adducts with glutathione
that reduce the intensity of the signal of the quantified species,
DTT was added to the sample during peptide recovery. The
amount of PKCi delivered inside cells by the three different
CPPs (Penetratin, Kno and (Arg)9) and the pseudo-peptidic
carriers P1 and P2 was measured using the protocol described in
Fig. 4. It was compared to the uptake of the free PKCi. To avoid
the dimerization of the free cargo H-PKCi-SH during incubation
with cells, the sulfhydryl group was reacted with iodoacetamide
to give the peptide H-PKCi-SAcm. The corresponding
Fig. 4. Quantification of the internalized PKCi cargo by MALDI-TOF MS. (a) Cells are incubated with the conjugate. (b) Cells are washed. (c) Membrane-bound
conjugate is digested by trypsin then trypsin inhibitor is added. (d) A known and adequate amount of internal standard is added, cell lysis is performed in 0.3% Triton
X100, 1 M NaCl and the sample is heated for 15 min at 100 °C. (e) Biotinylated peptides are captured by streptavidin-coated magnetic beads in presence of DTT. (f)
Beads are washed and analyzed by MALDI-TOF MS. The ratio between the MH+ peak areas of H-cargo-SH and D-cargo-SH yields the absolute amount of
internalized cargo.
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sample during peptide capture by the streptavidin-coated
beads. No D-PKCi-SH was observed in the mass spectra
showing that in situ alkylation of the cysteine was complete.
The free cargo or the cargo-carrier conjugates were incubated
at a concentration of 7.5 μM for 75 min at 37 °C. In these
conditions, the amount of free cargo internalized in 106 CHO
cells was found to be 0.7±0.1 pmol (Fig. 3C). The amount of
intact intracellular PKCi was enhanced 4 times compared to the
reference when the PKCi peptide was delivered by the pseudo-
peptides P1 and P2 and up to 26 times when it was delivered
by Kno (Fig. 3C). When Kno was used as carrier, the esti-
mated intracellular concentration of intact PKCi was found to
be 12.3±0.5 μM. No intense signals corresponding to an intra-
cellular degradation of PKCi were detected in the mass spectra.
4. Discussion
4.1. Methods for the quantification of the CPP cellular uptake
and cargo delivery
Most of the methods described in the literature to measure
the CPPs cellular uptake give the total amount of internalized
peptide with no distinction between the intact and degraded
forms [13]. We have recently reported a method to quantify the
uptake of CPPs based on MALDI-TOF MS [25]. The use of
MALDI-TOF MS allows direct characterization of the different
species present in the sample. This gives different advantages.
The method provides the amount of intracellular intact CPP.
Distinction between the internalized peptide and the peptide
bound to the cell surface can be achieved by modification of the
extracellular peptide. In our protocol the membrane-bound
peptide is digested by trypsin. Digests are expected to have a
reduced affinity for the cell membrane and to be removed by
washing. Even if some of the peptide fragments retain affinityfor the membrane and are not eliminated, they can still be
distinguished from intracellular intact peptide by their molec-
ular weight. As demonstrated earlier, the use of MALDI-TOF
MS also allows the direct comparison of the uptake efficiencies
of different peptides incubated together for screening experi-
ments [25]. Finally, it potentially enables the study of CPP
modifications occurring inside cells such as degradation.
MALDI-TOF MS is not a quantitative technique. Peptide
quantification can only be achieved by using an internal
standard which consists of a peptide with the same sequence
and labeled with a stable isotope. In our method to quantify the
uptake of free CPPs, the CPP is functionalized by an isotope tag
containing four non-deuterated or bi-deuterated glycine resi-
dues. The method gives the total amount of CPP protected
against extracellular trypsin digestion which is assimilated to
intracellular peptide. This amount should result from the CPP
internalization and its potential intracellular degradation. Only
trypsin-sensitive carriers can be studied with this protocol. For
non-peptidic carriers, the discrimination between intracellular
and membrane-associated peptides would be problematic.
In this study, the technique of quantification by MALDI-
TOF MS has been adapted to measure the amount of cargo
delivered inside cells by a carrier. To enable its quantification,
the cargo is functionalized by the isotope tag previously
described. It is linked to the carrier via a disulfide bridge (Fig.
1B). With this construction, it is now the capacity of a CPP to
act as a Trojan carrier that is studied. The cargo that was chosen
corresponds to a peptide inhibitor of protein kinase C (Fig. 1B).
This peptide contains several basic residues in its sequence so
that distinction between the internalized and the membrane-
bound peptide can still be performed by trypsin digestion. This
new method is used to compare the efficiency of different
carriers to transport the same cargo. It is very useful for the
study of non-peptidic carriers because it solves the problem of
discrimination between the internalized and membrane-bound
381B. Aussedat et al. / Biochimica et Biophysica Acta 1758 (2006) 375–383species. Since, in this case, it is always the same species that is
quantified, the quantification sensibility is similar in all
experiments and most importantly problems related to differ-
ences of accessibility or sensitivity to trypsin of the membrane-
bound peptide are avoided. This method gives the amount of
intact intracellular cargo resulting from its delivery and its
potential intracellular degradation. The intracellular stability of
the cargo most probably depends on the carrier used since it can
address the cargo to different intracellular compartments. This
method thus gives important information for the choice of the
best carrier since only the intact cargo will provide the expected
biological activity.
4.2. Comparison of the efficiencies of PKCi delivery by various
carriers
It was found here that the free PKCi peptide (PKCi-SAcm) is
internalized in CHO cells but with very low efficiency.
However, all the CPPs and pseudo-peptides that were
conjugated to PKCi increased the cargo intracellular concen-
tration showing that they all behave as carriers. Pseudo-peptidic
carriers P1 and P2 gave very similar results showing that the
loss of positive charges can be compensated by the addition of
indol groups. P1 and P2 are functionalized by ammoniums,
which have been shown in the literature to be less efficient than
guanidiniums to promote membrane translocation [43]. Guani-
dylation of the bis-ornithine side-chains may enhance the
pseudo-peptides cellular uptake. The CPPs (Arg)9, Penetratin
and the third helix of Knotted were found to be more efficient to
deliver PKCi. Kno gave the best result and was found to be the
only carrier leading to an intracellular concentration of intact
cargo (12.3±0.5 μM) higher than the concentration of
conjugate applied outside cells (7.5 μM).
Previous experiments performed with neurons [35] or
human foreskin fibroblasts [34] have shown that the
unconjugated PKCi peptide had no biological effect probably
because it cannot reach its cytosolic target. Conjugation of
PKCi to Penetratin led to 80% inhibition of the phorbol ester-
stimulated PKC in neurons [35]. It will now be interesting to
see if the same effects are observed in CHO cells and
correlate the biological data with the quantification results.
This will indicate whether the PKCi internalized alone or
conjugated to the different Trojan carriers is able to reach its
cytosolic target or if it remains trapped in cellular compart-
ments such as endosomes.
4.3. Comparison between the efficiencies of free CPP uptake
and cargo delivery
Two types of experiments have been done to characterize
(Arg)9, Penetratin and Kno: the quantification of free CPP
cellular uptake and the measure of cargo internalization when
conjugated to a carrier (comparison of data presented in Fig. 3B
and 3C). In the case of (Arg)9, the intracellular amounts of CPP
and cargo were similar. In contrast, the amount of cargo
delivered by Penetratin was higher than the amount of free
Penetratin internalized. The opposite result was obtained forKno. The differences observed when measuring the internalized
conjugated cargo or the free CPP suggest an effect of the cargo
attachment to the CPP on the efficiency of uptake. In the case of
Penetratin there might be a positive cooperative effect between
the CPP and the cargo for internalization. Another possible
explanation is that the differences observed between both type
of experiments reflect different rates of intracellular degradation
for the cargo and the CPP. Indeed, in both cases, it is the amount
of intact species that is measured. No intense signals of
intracellular digests have been detected on the mass spectra for
the CPPs or the PKCi. However, it cannot be excluded that a
fraction of the internalized peptides has been completely
digested and is not detected by MALDI-TOF MS or that the
degraded fragments have leaked out of the cells. The free CPP
and the CPP-cargo conjugate may enter cells via different
pathways and may be addressed to different compartments
leading to different degradation rates. The study of conjugates
with the cargo and the carrier both labelled with the isotope tag
and the biotin may help answering these questions.
5. Conclusion
We have reported here a new method to quantify the
efficiency of cargo delivery based on MALDI-TOF mass
spectrometry. The cargo that was chosen corresponds to a
trypsin-sensitive peptide allowing the easy and accurate
distinction between the internalized and membrane-bound
cargo. This method present the major advantage to be applicable
to the study of peptidic as well as non-peptidic carriers. Two new
pseudo-peptidic carriers incorporating in their sequence theα,α-
disubstituted amino acid bis-orthinine have been examined here.
Work is in progress to study the effect of different functionaliza-
tion of the side-chains of this amino acid on cellular uptake.
Finally, the efficiencies of cellular uptake and cargo delivery of
three CPPs have been compared. The peptide corresponding to
the third helix of Knotted-1 homeodomain appears as a new
promising Trojan peptide exhibiting an improved efficiency of
cargo delivery compared to the already widely used CPPs
Penetratin and (Arg)9. It will now be interesting to evaluate the
biological activity of the cargo when delivered by these different
carriers and to analyze the cytotoxicity of the carriers.
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